克利夫兰生物实验室

CBLI NASDAQ
1.470
-0.038
-2.49%
休市 16:00 05/24 EDT
开盘
1.530
昨收
1.508
最高
1.530
最低
1.470
成交量
1,099
成交均量(3M)
2.53万
52周最高
3.160
52周最低
1.000
换手率
0.01%
市值
1,660.84万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供克利夫兰生物实验室 CBLI股票价格,克利夫兰生物实验室股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
展开 >

最近浏览

名称
价格
涨跌幅